Search Results for 'aml patients'

aml patients published presentations and documents on DocSlides.

The new (2021) ELN AML MRD guidelines
The new (2021) ELN AML MRD guidelines
by sylvia
Yishai Ofran 2021. The general idea of MRD measure...
Acute myeloid leukemia (AML)
Acute myeloid leukemia (AML)
by LoudAndProud
Justyna Rybka. Department of . Haematology. , Bloo...
CLASSIFICATION OF AML  &
CLASSIFICATION OF AML &
by VanillaSky
PROGNOSTIC FACTORS. Although the first published r...
Case Discussion
Case Discussion
by breezeibm
Hb. 6.6, platelet count . 17,000. Bone . marrow b...
Understanding Evolving Treatment Paradigms for Older Adults
Understanding Evolving Treatment Paradigms for Older Adults
by alexa-scheidler
Farhad. . Ravandi. , . MD. Professor of Medicine...
11/03/14 Personalized Approach in Acute and Chronic Leukemias
11/03/14 Personalized Approach in Acute and Chronic Leukemias
by kittie-lecroy
Emmanuel C. Besa, M.D.. Professor of Medical Onco...
Azacitidine use in post transplant relapse of MDS and AML
Azacitidine use in post transplant relapse of MDS and AML
by test
Jennifer Vaughn, MD. Bart Scott, MD. Myelodysplas...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by likets
proceedings from the live CME event and may includ...
Updated Results From a Phase 2 Study of Pracinostat in Combination Wit
Updated Results From a Phase 2 Study of Pracinostat in Combination Wit
by melody
BACKGROUNDElderly patients with acute myeloid leuk...
Inherited bone marrow failure syndromes
Inherited bone marrow failure syndromes
by amelia
Josu. de la . Fuente. Departments of Paediatrics ...
Who, when and how to transplant
Who, when and how to transplant
by LadyInRed
adults with . AML. Prof C Craddock CBE. Queen Eliz...
Page 2 of 4McGrathand Smink J Med Case Reports          2021 15228
Page 2 of 4McGrathand Smink J Med Case Reports 2021 15228
by isabella
signicance dicult to ascertain []. ere are nume...
Journal of Islamabad Medical  D
Journal of Islamabad Medical D
by evans
ental College (JIMDC); 201 3 ;2 ( 4 ): 58 - 63 58 ...
UPDATES IN HEMATOLOGYONCOLOGY
UPDATES IN HEMATOLOGYONCOLOGY
by jasmine
Acute Myeloid Leukemia: A Review ARI PELCOVITS, M...
Investor Presentation Seeking $500,000 Convertible Note Financing,
Investor Presentation Seeking $500,000 Convertible Note Financing,
by danika-pritchard
P. receding $13MM Series B Round . NON-CONFIDENT...
Case 121
Case 121
by olivia-moreira
Marisa Juntilla, MD, PhD. Stanford University Med...
Targeted Therapy in Acute Myeloid Leukemia
Targeted Therapy in Acute Myeloid Leukemia
by ellena-manuel
Ross . L. Levine M.D.. Human Oncology and Pathoge...
Targeted therapies against Acute Myeloid Leukemia
Targeted therapies against Acute Myeloid Leukemia
by triclin
Hiba . El Hajj, Ph.D.. Assistant Professor, . Depa...
Current diagnosis of  acute
Current diagnosis of acute
by alis
myeloid leukemia. Jacqueline Cloos. Pediatric. . ...
Adult Acute Myeloid
Adult Acute Myeloid
by daniella
A Guide for Being diagnosed with acute myeloid le...
Supervisor: VS  高志平
Supervisor: VS 高志平
by jovita
Reporter: R4 . 張妙而. Introduction. . Mutatio...
Diagnosis and management of acute myeloid leukemia in children and
Diagnosis and management of acute myeloid leukemia in children and
by crunchingsubway
adolescents: recommendations from an international...
Recruitment of cancer patients by LCRN
Recruitment of cancer patients by LCRN
by karlyn-bohler
Subspecialty: Haem . Onc. & Lymphoma . Recr...
Targeting Disease at the Nuclear Pore
Targeting Disease at the Nuclear Pore
by yoshiko-marsland
Corporate Presentation. August 2015. NASDAQ: KPTI...
Case Study:
Case Study:
by conchita-marotz
Patient with MF has Increasing . B. lasts, but No...
Targeting Disease at the Nuclear Pore
Targeting Disease at the Nuclear Pore
by phoebe-click
Corporate Presentation. August 2015. NASDAQ: KPTI...
Identification of mutations prognostic of relapse after all
Identification of mutations prognostic of relapse after all
by test
P Ferguson, L . Quek. , M . Metzner. , I Ahmed, C...
Tailoring Reduced-Intensity
Tailoring Reduced-Intensity
by eurolsin
Conditioning: . Applying Emerging Evidence to Clin...
APACITABINE
APACITABINE
by payton
S Winter 2018 - 19 DNA Damage Response (DDR) Prog...
XOSPATA TM   (gilteritinib)
XOSPATA TM (gilteritinib)
by udeline
– monotherapy for the treatment of relapsed or r...
Welcome! To join the call dial (866) 740-1260, passcode 3754894#.
Welcome! To join the call dial (866) 740-1260, passcode 3754894#.
by OptimisticPanda
All participants are placed on mute for the durati...
x0000x0000  xMCIxD 0 xMCIxD 0  xMCIxD 1 x
x0000x0000 xMCIxD 0 xMCIxD 0 xMCIxD 1 x
by thomas
The results of the phase 3 QuANTUM FLT3 inhibitor,...
Abnormal blood test Diagnosis of MDS
Abnormal blood test Diagnosis of MDS
by blanko
3 YEARS. Demographics of Germany. . [1910 – 205...
Focusing on Health Equity in Hematology
Focusing on Health Equity in Hematology
by ivy
. Press Briefing. Moderator: Alison Walker. , MD, ...
Myelodysplastic syndromeGuru Subramanian Guru Murthy MDAssistant profe
Myelodysplastic syndromeGuru Subramanian Guru Murthy MDAssistant profe
by jalin
Clonal hematopoietic disorder multilineage hematop...
Key Presentations from the 63rd American Society of Hematology (ASH) Annual Meeting:
Key Presentations from the 63rd American Society of Hematology (ASH) Annual Meeting:
by danya
Acute Myeloid Leukemia and Myelodysplastic Syndrom...
Akiko Shimamura, MD, PhD
Akiko Shimamura, MD, PhD
by ivy
Professor of Pediatrics, Harvard Medical School. D...
Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia
Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia
by grace3
John-William . Sidhom. , MD/PhD Candidate ’21. D...
 Evolving Therapies for Elderly Patients with Blood Cancers
Evolving Therapies for Elderly Patients with Blood Cancers
by alida-meadow
Andrew Artz, MD, MS. Associate Professor of Medic...